| value |
{"aggregator_url":"https://news.google {"aggregator_url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNS2F2ZGNMbl9FNHhWSFA3d1RuRUNsOG9xTm9GZXZGTXRZb2NMRVFPdTdvSUxONC1pWVk5dHU4dnRsU2JoekR5d1FkMHY5OFhQWnM4X3ZqN0YwVDdXZ181cXM3Q2pjRWZQZW5DWUNIc01UWGE2S3g2YWNVb1RCOFRveWRBRUc1ZE1TMGJxamZYWmo3VzgzcXQ3SUZYQlo5UDM1ay1HY2pUQjMxNDVlMUxZNDB1MHd2MG1nelNXMQ?oc=5","as_of":"2026-04-20T14:20:31.041620+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNS2F2ZGNMbl9FNHhWSFA3d1RuRUNsOG9xTm9GZXZGTXRZb2NMRVFPdTdvSUxONC1pWVk5dHU4dnRsU2JoekR5d1FkMHY5OFhQWnM4X3ZqN0YwVDdXZ181cXM3Q2pjRWZQZW5DWUNIc01UWGE2S3g2YWNVb1RCOFRveWRBRUc1ZE1TMGJxamZYWmo3VzgzcXQ3SUZYQlo5UDM1ay1HY2pUQjMxNDVlMUxZNDB1MHd2MG1nelNXMQ?oc=5","article_chars":0,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_605792bfd612865d","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-20T14:21:05.907009+00:00","extraction_method":"none","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNS2F2ZGNMbl9FNHhWSFA3d1RuRUNsOG9xTm9GZXZGTXRZb2NMRVFPdTdvSUxONC1pWVk5dHU4dnRsU2JoekR5d1FkMHY5OFhQWnM4X3ZqN0YwVDdXZ181cXM3Q2pjRWZQZW5DWUNIc01UWGE2S3g2YWNVb1RCOFRveWRBRUc1ZE1TMGJxamZYWmo3VzgzcXQ3SUZYQlo5UDM1ay1HY2pUQjMxNDVlMUxZNDB1MHd2MG1nelNXMQ?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"investor.lilly.com","publisher_resolution":"payload_source_domain","requested_url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNS2F2ZGNMbl9FNHhWSFA3d1RuRUNsOG9xTm9GZXZGTXRZb2NMRVFPdTdvSUxONC1pWVk5dHU4dnRsU2JoekR5d1FkMHY5OFhQWnM4X3ZqN0YwVDdXZ181cXM3Q2pjRWZQZW5DWUNIc01UWGE2S3g2YWNVb1RCOFRveWRBRUc1ZE1TMGJxamZYWmo3VzgzcXQ3SUZYQlo5UDM1ay1HY2pUQjMxNDVlMUxZNDB1MHd2MG1nelNXMQ?oc=5","source_event_id":"evt_7db9f8b9fb34","source_quality":"empty","status_code":200,"version":"signal_enrichment_v2"},"fp":"78fa726ed0746a9f","published_at":"2026-04-20T13:04:06+00:00","publisher_domain":"investor.lilly.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.42,"dates_mentioned":[],"entities":[],"event_type":"other","information_gaps":["article_text_unavailable"],"key_facts":["Headline: Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company - investor.lilly.com","Source summary: Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company investor.lilly.com Exclusive | Eli Lilly Nears Deal for Cancer Biotech WSJ Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says Yahoo Eli Lilly nears $2B-plus deal for Kelonia to expand cancer pipeline: WSJ (LLY:NYSE) Seeking Alpha Report: Eli Lilly nearing $2B deal to acquire Boston-"],"numeric_claims":[],"primary_claim":"Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company - investor.lilly.com","relevance_score":0.46,"sentiment":"neutral","source_quality":"unknown","summary":"Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company investor.lilly.com Exclusive | Eli Lilly Nears Deal for Cancer Biotech WSJ Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says Yahoo Eli Lilly nears $2B-plus deal for Kelonia to expand cancer pipeline: WSJ (LLY:NYSE) Seeking Alpha Report: Eli Lilly nearing $2B dea","topics":["news headline"]},"source":"investor.lilly.com","source_domain":"investor.lilly.com","source_url":"https://investor.lilly.com","summary":"Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company investor.lilly.com Exclusive | Eli Lilly Nears Deal for Cancer Biotech WSJ Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says Yahoo Eli Lilly nears $2B-plus deal for Kelonia to expand cancer pipeline: WSJ (LLY:NYSE) Seeking Alpha Report: Eli Lilly nearing $2B deal to acquire Boston-based biotech Indianapolis Business Journal","title":"Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company - investor.lilly.com","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp"}... |